3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
88
INDUSTRY
6
OTHER_GOV
4
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Dermatologic
1
Conditions
Melanoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
39
Magnetic Resonance Spectroscopy
30
Carboplatin
14
Biopsy
14
Radiation
13
Cyclophosphamide
13
Radiotherapy
11
daratumumab
10
Vincristine
10
Dexamethasone
10
Surgical Procedures, Operative
9
Etoposide
9
Lenalidomide
8
X-Rays
7
Observation
7
Leucovorin
7
Irinotecan
7
Doxorubicin
7
Cisplatin
7
durvalumab
6
dexamethasone acetate
6
dexamethasone 21-phosphate
6
auricularum
6
Watchful Waiting
6
Radiosurgery
6
Docetaxel
6
Calcium Dobesilate
6
pembrolizumab
5
Stem Cell Transplantation
5
Standard of Care
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
NETWORK
×
Immune Checkpoint Inhibitors
×
Clear all
NCT05522660
2026-04-27
USZ-STRIKE
ETOP IBCSG Partners Foundation
Phase 3
Recruiting
180 enrolled